Kelly de Ligt, PhD, discusses subgroups of symptom burden seen in breast cancer survivors.
Kelly de Ligt, PhD
Advertisement
Articles by Kelly de Ligt, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pan-RAS Molecular Glue ERAS-0015 for Metastatic Pancreatic Adenocarcinoma
2
FDA Grants Priority Review to Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
3
European Commission Approves Sacituzumab Govitecan Plus Pembrolizumab for Frontline PD-L1+ mTNBC
4
Darlifarnib Plus Cabozantinib Displays Early Signals of Safety and Efficacy in RCC
5